In the Journals

Vitamin D supplements linked to less cartilage, joint loss in knee OA

July 29, 2019
Among patients with knee osteoarthritis, higher intake with both vitamins C and D is associated with less cartilage degeneration, while…
In the Journals

Upadacitinib outperforms adalimumab in methotrexate-refractory RA

July 29, 2019
Upadacitinib, a JAK1 inhibitor, is superior to adalimumab and placebo at improving signs, symptoms and physical function among patients with…

Personalized Stem Cells Inc gets new drug application clearance to use stem cells for knee OA

July 28, 2019
Personalized Stem Cells Inc. announced it has received FDA approval for an investigational new drug application for the use of adipose-derived stem…
In the Journals

Pneumocystis pneumonia prophylaxis guidelines would be ‘helpful,’ ID docs say

July 26, 2019
A survey of infectious disease clinicians showed there is “little consensus” regarding Pneumocystis pneumonia prophylaxis for patients…
Perspective

FDA approves boxed warning for Xeljanz in UC

July 26, 2019
The FDA on Friday issued a safety alert and approved new Boxed Warning for the 10-mg, twice-daily dosage of tofacitinib in patients with ulcerative…
FDA News

FDA panel supports approval of nintedanib for systemic sclerosis-associated ILD

July 26, 2019
The FDA Arthritis Advisory Committee voted 10-7 to recommend approval of nintedanib for treatment of systemic sclerosis-associated interstitial lung…
In the Journals

Low disease activity state in SLE linked to reduced health care costs

July 26, 2019
Achieving a low disease activity state in systemic lupus erythematosus that is maintained for 50% or more of the time is associated with…
In the Journals

Consumption of heavy metals in fish during pregnancy increases risk for JIA

July 25, 2019
Consuming moderate amounts of heavy metals contained in fish during pregnancy or early childhood may adversely impact the child’s immune…
In the Journals

Women, blacks, most frequently receive chronic opioid prescriptions

July 25, 2019
Patients who were black, women or who were at risk for opioid-related harm were more likely to be prescribed chronic opioids, according to findings…
In the Journals

TNF-inhibitor tapering as effective as standard dose in axial SpA

July 25, 2019
Mild TNF inhibitor tapering is about as efficacious as the standard dose treatment in achieving inactive disease in patients with axial…
FDA News

FDA approves Hadlima, fourth Humira biosimilar

July 24, 2019
The FDA has approved the fourth biosimilar to adalimumab, adalimumab-bwwd, for all eligible indications of the biologic product, according to a…
In the Journals

EULAR: Patients with large-vessel vasculitis should be screened for CV risk

July 24, 2019
All patients with large-vessel vasculitis should be screened for treatment-related cardiovascular comorbidities, with prophylaxis and life-style…
In the Journals

Socioeconomic factors may moderate racial disparities in OA function

July 23, 2019
Although black adults with knee osteoarthritis demonstrate worse performance-based physical function than white patients, these disparities are…
FDA News

FDA approves Ruxience, biosimilar to Rituxan, for blood cancers, autoimmune conditions

July 23, 2019
The FDA approved rituximab-pvvr, a biosimilar to rituximab, for multiple indications. Rituximab-pvvr (Ruxience, Pfizer) is the second biosimilar to…
Breaking News

Senators announce bipartisan plan to lower drug prices

July 23, 2019
Two lawmakers introduced legislation today that they said would lower the price of prescription drugs for Americans, according to a press release. …
In the JournalsPerspective

Filgotinib improves RA signs, symptoms in DMARD-refractory patients

July 23, 2019
Patients with rheumatoid arthritis who previously had an inadequate response to biologic DMARDs demonstrated improved signs and symptoms after…

$1.4 billion settlement against opioid manufacturer puts spotlight on generic drugs, treatment gaps

July 23, 2019
The lawsuit involving the manufacturer of Suboxone film that was settled earlier this month for a record-breaking $1.4 billion could change the…
FDA News

FDA approves first generic alternatives to Lyrica

July 22, 2019
The FDA has approved several generic versions of pregabalin for the treatment of patients with neuropathic pain related to diabetic neuropathy…
In the Journals

Hand with clinically more swollen joints best for ultrasound monitoring in RA

July 22, 2019
Among patients with rheumatoid arthritis, the hand with more clinically swollen joints is likely to be the best option for monitoring ultrasound…
FDA News

FDA approves Otezla for oral ulcers linked to Behçet’s disease

July 19, 2019
The FDA has approved apremilast 30 mg twice daily for the treatment of adult patients with oral ulcers associated with Behçet’s disease…